Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine.


Journal

Pain medicine (Malden, Mass.)
ISSN: 1526-4637
Titre abrégé: Pain Med
Pays: England
ID NLM: 100894201

Informations de publication

Date de publication:
08 09 2021
Historique:
pubmed: 5 3 2021
medline: 14 9 2021
entrez: 4 3 2021
Statut: ppublish

Résumé

Previous studies have demonstrated that emotional stress, changes in lifestyle habits and infections can worsen the clinical course of migraine. We hypothesize that changes in habits and medical care during coronavirus disease 2019 (COVID-19) lockdown might have worsened the clinical course of migraine. Retrospective survey study collecting online responses from migraine patients followed-up by neurologists at three tertiary hospitals between June and July 2020. We used a web-based survey that included demographic data, clinical variables related with any headache (frequency) and migraine (subjective worsening, frequency, and intensity), lockdown, and symptoms of post-traumatic stress. The response rate of the survey was 239/324 (73.8%). The final analysis included 222 subjects. Among them, 201/222 (90.5%) were women, aged 42.5 ± 12.0 (mean±SD). Subjective improvement of migraine during lockdown was reported in 31/222 participants (14.0%), while worsening in 105/222 (47.3%) and was associated with changes in migraine triggers such as stress related to going outdoors and intake of specific foods or drinks. Intensity of attacks increased in 67/222 patients (30.2%), and it was associated with the subjective worsening, female sex, recent insomnia, and use of acute medication during a headache. An increase in monthly days with any headache was observed in 105/222 patients (47.3%) and was related to symptoms of post-traumatic stress, older age and living with five or more people. Approximately half the migraine patients reported worsening of their usual pain during the lockdown. Worse clinical course in migraine patients was related to changes in triggers and the emotional impact of the lockdown.

Identifiants

pubmed: 33659991
pii: 6154429
doi: 10.1093/pm/pnaa449
pmc: PMC8108628
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2079-2091

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the American Academy of Pain Medicine.All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Alicia Gonzalez-Martinez (A)

Headache Unit, Department of Neurology, Hospital Universitario de La Princesa & Instituto de Investigación Sanitaria de La Princesa, Madrid, Spain.
Department of Neurology, Universidad Autónoma de Madrid, Madrid, Spain.

Álvaro Planchuelo-Gómez (Á)

Imaging Processing Laboratory, Universidad de Valladolid, Valladolid, Spain.

Ángel L Guerrero (ÁL)

Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Department of Medicine, Universidad de Valladolid, Valladolid, Spain.

David García-Azorín (D)

Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

Sonia Santos-Lasaosa (S)

Headache Unit, Department of Neurology, Hospital Clínico Universitario Lozano Blesa & Aragon Institute for Health Research (IIS Aragón), Zaragoza, Spain.

María Pilar Navarro-Pérez (MP)

Headache Unit, Department of Neurology, Hospital Clínico Universitario Lozano Blesa & Aragon Institute for Health Research (IIS Aragón), Zaragoza, Spain.

Paula Odriozola-González (P)

Department of Psychology, Universidad de Valladolid, Valladolid, Spain.

María Jesús Irurtia (MJ)

Department of Psychology, Universidad de Valladolid, Valladolid, Spain.

Sonia Quintas (S)

Headache Unit, Department of Neurology, Hospital Universitario de La Princesa & Instituto de Investigación Sanitaria de La Princesa, Madrid, Spain.
Department of Neurology, Universidad Autónoma de Madrid, Madrid, Spain.

Rodrigo de Luis-García (R)

Imaging Processing Laboratory, Universidad de Valladolid, Valladolid, Spain.

Ana Beatriz Gago-Veiga (AB)

Headache Unit, Department of Neurology, Hospital Universitario de La Princesa & Instituto de Investigación Sanitaria de La Princesa, Madrid, Spain.
Department of Neurology, Universidad Autónoma de Madrid, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH